Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 786301, 7 pages
http://dx.doi.org/10.1155/2014/786301
Clinical Study

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin

1Pediatric Intensive Care Unit, University General Hospital Gregorio Marañón, Calle Doctor Castelo 47, 28009 Madrid, Spain
2Statistics, Preventive Medicine and Quality Service, University General Hospital Gregorio Marañón, Complutense University, Madrid, Spain

Received 10 March 2014; Revised 10 June 2014; Accepted 12 June 2014; Published 3 August 2014

Academic Editor: Raul Lombardi

Copyright © 2014 Sara Nicole Fernández et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. del Castillo, J. López-Herce, E. Cidoncha et al., “Circuit life span in critically ill children on continuous renal replacement treatment: A prospective observational evaluation study,” Critical Care, vol. 12, no. 4, article R93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. Zhang and N. Hongying, “Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy,” Intensive Care Medicine, vol. 38, no. 1, pp. 20–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Elhanan, P. Skippen, G. Nuthall, G. Krahn, and M. Seear, “Citrate anticoagulation in pediatric continuous venovenous hemofiltration,” Pediatric Nephrology, vol. 19, no. 2, pp. 208–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Chadha, U. Garg, B. A. Warady, and U. S. Alon, “Citrate clearance in children receiving continuous venovenous renal replacement therapy,” Pediatric Nephrology, vol. 17, no. 10, pp. 819–824, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Morabito, V. Pistolesi, L. Tritapepe et al., “Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution,” Critical Care, vol. 16, no. 3, article R111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. H. U. Meier-Kriesche, J. Gitomer, K. Finkel, and T. DuBose, “Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation,” Critical Care Medicine, vol. 29, no. 4, pp. 748–752, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. G. R. Hetzel, M. Schmitz, H. Wissing et al., “Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial,” Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 232–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. G. H. Betjes, D. van Oosterom, M. van Agteren, and J. van de Wetering, “Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding,” Journal of Nephrology, vol. 20, no. 5, pp. 602–608, 2007. View at Google Scholar · View at Scopus
  9. N. Fealy, I. Baldwin, M. Johnstone, M. Egi, and R. Bellomo, “A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration,” The International Journal of Artificial Organs, vol. 30, no. 4, pp. 301–307, 2007. View at Google Scholar · View at Scopus
  10. D. J. Kutsogiannis, R. T. N. Gibney, D. Stollery, and J. Gao, “Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients,” Kidney International, vol. 67, no. 6, pp. 2361–2367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Monchi, D. Berghmans, D. Ledoux, J. Canivet, B. Dubois, and P. Damas, “Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study,” Intensive Care Medicine, vol. 30, no. 2, pp. 260–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. H. M. Oudemans-van Straaten, R. J. Bosman, M. Koopmans et al., “Citrate anticoagulation for continuous venovenous hemofiltration,” Critical Care Medicine, vol. 37, no. 2, pp. 545–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Santiago, J. López-Herce, J. Urbano et al., “Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study,” Critical Care, vol. 13, article R184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Schultheiß, B. Saugel, V. Phillip et al., “Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study,” Critical Care, vol. 16, no. 4, article R162, 2012. View at Publisher · View at Google Scholar · View at Scopus